Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Q&a

<< Previous

Bullboard Posts

Next >>

Comment by emerald03on Apr 19, 2023 6:15pm

95 Views

Post# 35403996

RE:Q&a

well
sleepyhoward , you are clear and correct .Don't know what happened to Biorun or Putinkhuylo,they are good people ,but reality has struck here now ,optimists sadly faded away as we awaken that we have been duped eg 1067 deal ,and each investors precious monies being wiped away .
As I have said ,sale of company to me is only option to get out of this misery and get some money back ,rather than continued false claims and serial dilution taking us below 5 cents in a stock death spiral .

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario